Update on the management of uveitis in children: an overview for the clinician

References

• Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of Uveitis Nomenclature (SUN) Working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;14:509–516.
   Google Scholar
• Agrawal RV, Murthy S, Sangwan V, et al. Current approaches in diagnosis and management of anterior uveitis. Indian J Ophthalmol. 2010;58(1):11–19.
   PubMed Web of Science ®Google Scholar
• Manohar Babu B, Rathinam SR. Intermediate Uveitis. Indian J Ophthalmol. 2010;58(1):21–27.
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Ganesh SK, Biswas J. Current approaches in the diagnosis and management of posterior uveitis. Indian J Ophthalmol. 2010;58(1):29–43.
   PubMed Web of Science ®Google Scholar
• Purvein V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuroophthalmol. 2011;31(1):58–68.
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta V, Gupta A. Current approach in the diagnosis and management of panuveitis. Indian J Ophthalmol. 2010;58(1):45–54.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT. Uveitis: contrasting the approaches in Japan and the United States. Jpn J Ophthalmol. 2019;63(1):1–6.
   PubMed Web of Science ®Google Scholar
• Cann M, Ramanan AV, Crawford A, et al. Outcomes of non-infectious paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol. 2018;16(1):1.
   PubMedGoogle Scholar
• Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259‒269.
   PubMedGoogle Scholar
• Thorne JE, Suhler E, Skup M. Prevalence of noninfectious uveitis in the United States: a claims-based analysis. JAMA Ophthalmol. 2016;134(11):1237–1245.
   PubMed Web of Science ®Google Scholar
• Barisani-Asenbaur T, Maca SM, Mejdoubi L, et al. Uveitis – a rare disease often associated with systemic diseases and infectious – a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57.
   PubMed Web of Science ®Google Scholar
• McCannel CA, Holland GN, Helm CJ, et al. UCLA community-based uveitis study group. Causes of uveitis in general practice of ophthalmology. Am J Ophthalmol. 1996;121(1):35–46.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Calonge M, Pedroza-Series M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114(5):593–599.
   PubMed Web of Science ®Google Scholar
• Wentworth BA, Freitas-Neto CA. Management of pediatric uveitis. Nat Inst Health. 2014;2(6):41.
   Google Scholar
• Majumder PD, Biswas J. Pediatric uveitis: an update. Oman J Ophthalmol. 2013;6(3):140–150.
   PubMedGoogle Scholar
• Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299‒2306.
   Web of Science ®Google Scholar
• Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544‒1551.
   Web of Science ®Google Scholar
• Hayworth JL, Turk MA, Nevskaya T, et al. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases. Joint Bone Spine. 2019 Jun 14. pii: S1297-319X(19)30092-2.
   PubMedGoogle Scholar
• Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–778.
   PubMed Web of Science ®Google Scholar
• Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am J Ophthalmol. 2009;147(4): 667–678. e665.
   PubMed Web of Science ®Google Scholar
• Kanski JJ, Arthritis J. Uveitis. Surv Ophthalmol. 1990;34:253–267.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Minden K, Tappeiner C, et al. Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Seminars in Arthritis and Rheumatism. 2019 Aug;49(1):43-55.
   Google Scholar
• Boer JD, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87(7):879–884.
   PubMed Web of Science ®Google Scholar
• Tse SML, Laxer RM. New advances in juvenile spondyloarthritis. Nat Rev Rheumatol. 2012;8:269–279.
   PubMed Web of Science ®Google Scholar
• Adrovic A, Barut K, Sahin S, et al. Juvenile Spondyloarthropathies. Curr Rheumatol Rep. 2016;18:55.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Misra DP. Enthesitis-related arthritis. Clin Rheumatol. 2015;34:1839–1846.
   PubMed Web of Science ®Google Scholar
• Ferucci ED, Majka DS, Parrish LA, et al. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheumatol. 2005;52:239–246.
   PubMedGoogle Scholar
• Hinks A, Bowes J, Cobb J, et al. Fine-Mapping the MHC locus in Juvenile Idiopathic Arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. Ann Rheumatic Dis. 2017 Apr;76(4):765-772.
   Google Scholar
• Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25(10):1991–1994.
   PubMedGoogle Scholar
• Cassidy J, Kivlin J, Lindsley C, et al. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006;117(5):1843–1845.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Ringold S, Beukelman T, et al. American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol. 2019;71(6):864–877.
   PubMed Web of Science ®Google Scholar
• Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Best Pract Res Clin Rheumatol. 2017;31(4):517–534.
   PubMed Web of Science ®Google Scholar
• Lee JJY, Duffy CM, Guzman J, et al. Prospective determination of the incidence and risk factors of new-onset uveitis in juvenile idiopathic arthritis: the research in arthritis in Canadian children emphasizing outcomes cohort. Am College Rheumatol. 2018 Oct 15. doi: 10.1002/acr.23783.
   Google Scholar
• Ma SP, Rogers SL, Hall AJ, et al. Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis. Am J Ophthalmol. 2019;198:30–36.
   PubMed Web of Science ®Google Scholar
• Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol. 1986;30:215–228.
   PubMed Web of Science ®Google Scholar
• Jamilloux Y, Kodjikian L, Broussolle C, et al. Sarcoidosis and uveitis. Autoimmun Rev. 2014;13(8):840–849.
   PubMed Web of Science ®Google Scholar
• Holland GN, Stiehm RE. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003;135(6):867–878.
   PubMed Web of Science ®Google Scholar
• Dana M, Merayo-Lloves J, Schaumberg DA, et al. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996;103:1846–1853.
   PubMed Web of Science ®Google Scholar
• Cirone D, Cimino L, Spinucci G. Uveitis and internuclear ophthalmoplegia as ocular manifestations of sarcoidosis. Saudi J Ophthalmol. 2018;32(2):167–170.
   PubMed Web of Science ®Google Scholar
• Caplash S, Gangaputra S. Treatment challenges in an atypical presentation of tubulointerstitial nephritis and uveitis (TINU). Am J Ophthalmol. 2018;10:253–256.
   Google Scholar
• Okafor LO, Hewins P, Murray PI, et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors. Orphanet J Rare Dis. 2017;12(1):128.
   PubMedGoogle Scholar
• Clive DM, Vanguri VK. The syndrome of tubulointerstitial nephritis with uveitis (TINU). Am J Kidney Diseases. 2017;72(1):118–128.
   Web of Science ®Google Scholar
• Ozdal P, Berker N, Tugal-Tutkun I. Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res. 2015;10(4):469–480.
   PubMedGoogle Scholar
• Nikkhah H, Ramezani A, Ahmadieh H, et al. Childhood Pars planitis; clinical features and outcomes. J Ophthalmic Vis Res. 2011;6(4):249–254.
   PubMedGoogle Scholar
• Caso F, Costa L, Rigante D, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13:1220–1229.
   PubMed Web of Science ®Google Scholar
• Wounters CH, Maes A, Foley KP, et al. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 12:33.
   PubMed Web of Science ®Google Scholar
• Wang X, Kuivaniemi H, Bonavita G, et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002;46:3041–3045.
   PubMed Web of Science ®Google Scholar
• Holland GN, Rosenbaum JT. The challenge of blau syndrome. Am J Ophthalmol. 2018 Mar;187:xviii-xix.
   Web of Science ®Google Scholar
• Rose CD, Doyle TM, Mcllvain-Simpson G, et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onsetgranulomatous arthritis. J Rheumatol. 2005;32:373–375.
   PubMed Web of Science ®Google Scholar
• Carreno E, Guly CM, Chilov M, et al. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau Syndrome). Acta Ophthalmol. 2015;93(3):253–257.
   PubMed Web of Science ®Google Scholar
• Sarens IL, Casteels I, Anton J, et al. Blau syndrome-associated uveitis: preliminary results from an international perspective interventional case series. Am J Ophthalmol. 2018;187:158–166.
   PubMed Web of Science ®Google Scholar
• Priori R, Bombardieri M, Spinelli F, et al. Sporadic blau syndrome with a double CARD15 mutatino. Report of a case with a lifelong follow-up. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:228–231.
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Kikuchi T, Ohta K, et al. Ocular manifestations in blau syndrome associated with CARD15/NOD2 mutation. Ophthalmology. 2003;110:2040–2044.
   PubMed Web of Science ®Google Scholar
• Quartier P, Baptiste A, Despert V, et al. Adjuvite: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheumatic Dis. 2018;77(7):1003–1011.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646.
   PubMed Web of Science ®Google Scholar
• Bou R, Adan A, Borras F, et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int. 2015;35(5):777–785.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, et al. German uveitis in childhood study G. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46(6):1015–1019.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Ringold S, Beukelman T, et al. American college of rheumatology/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol. 2019;71(6):864–877.
   PubMed Web of Science ®Google Scholar
• Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018.
   Google Scholar
• Sood AB, Angeles-Han ST. An update on treatment of pediatric chronic non-infectious uveitis. Curr Treatm Opt Rheumatol. 2017 3;Mar(1):1–16.
   Google Scholar
• Mehta PJ, Alexander JL, Sen HN. Pediatric uveitis: new and future treatments. Curr Opin Ophthalmol. 2013;24(5):453–462.
   PubMed Web of Science ®Google Scholar
• Bratton ML, He YG, Weakley DR. Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis. J Aapos. 2014;18(2):110–113.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Altaweel MM, Holbrook JT, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118(10):1916–1926.
   PubMed Web of Science ®Google Scholar
• Simonini G, Paudyal P, Jones GT, et al. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology (Oxford). 2013;52(5):825–831.
   PubMed Web of Science ®Google Scholar
• Chang PY, Giuliari GP, Shaikh M, et al. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond). 2011;25(4):427–435.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Roesel M, Heinz C, et al. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye (Lond). 2009;23(5):1192–1198.
   PubMed Web of Science ®Google Scholar
• Lerman MA, Burnham JM, Chang PY, et al. Response of pediatric uveitis to tumor necrosis factor-alpha inhibitors. J Rheumatol. 2013;40(8):1394–1403.
   PubMed Web of Science ®Google Scholar
• Calvo-Rio V, Santos-Gomez M, Calvo I, et al. Anti-Interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients. Arthritis Rheumatol. 2017 Mar;69(3):668–675.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Modorati G, Berchicci L, et al. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol. 2016;100(6):782–786.
   PubMed Web of Science ®Google Scholar
• Quiñones K, Cervantes-Castañeda RA, Hynes AY, et al. Outcomes of cataract surgery in children with chronic uveitis. J Cataract Refract Surg. 2009;35:725‒731.
   PubMed Web of Science ®Google Scholar
• Flynn HW Jr, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. 1988;95:1114–1119.
   PubMed Web of Science ®Google Scholar
• Yangzes S, Seth NG, Singh R, et al. Long-term outcomes of cataract surgery in children with uveitis. Indian J Ophthalmol. 2019 Apr;67(4):490–495.
   PubMed Web of Science ®Google Scholar
• Kafkala C, Hynes A, Choi J, et al. Ahmed valve implantation for uncontrolled paediatric uveitic glaucoma. J Aapos. 2005;9:336‒340.
   PubMed Web of Science ®Google Scholar
• Bohnsack BL, Freedman SF. Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol. 2013 Jan;155(1):134–142.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Griffin KW, Harrison MJ, et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res. 2011;63(9):1254–1261.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Yeh S, McCracken C, et al. Using the effects of youngsters’ eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis. Arthritis Care Res. 2015;67(11):1513–1520. .
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Griffin KW, Lehman TJA, et al. The importance of visual function in the quality of life of children with uveitis. J Aapos. 2010;14(2). Russmann,W., Konig, U., Schlimbach, K., Pawlowska. DOI:10.1016/j.jaapos.2009.12.160
   PubMed Web of Science ®Google Scholar
• Kalinina AV, Ten CHA, van der Does P, et al. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010 Jun;149(6):994–999.e5.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Klotsche J, Sengler C, et al. Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study. Arthritis Rheumatol. 2018 Oct;70(10):1685–1694.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Klotsche J, Tappeiner C, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Rheumatology (Oxford). 2019 Jun 1;58(6):975–986.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Heinz C, Ganser G, et al. Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? J Rheumatol. 2012;39(6):1294–1295.
   PubMed Web of Science ®Google Scholar